Skip to main content

Advertisement

SpringerLink
Log in

CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantation

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Hemorrhagic cystitis (HC) is a common complication after transplantation. The purpose of this study was to examine the incidence and risk factors for HC after hematopoietic stem cell transplantation (HSCT). The records of patients who underwent allogenic HSCT from January 2012 to December 2018 at our institution were retrospectively reviewed. Cox proportional regression and Kaplan–Meier analyses were performed to determine independent risk factors for HC. The statistical analysis was performed in May 2020. A total of 173 patients underwent HSCT, and 53 (30.6%) developed grade 2 or 3 HC cystitis at a median of 37 days (range − 5 to 98 days) after transplantation. Thirty-two patients developed moderate (grade 2) cystitis and 21 severe (grade 3) cystitis. Of the 173 patients, 61 developed acute graft-versus-host disease (GVHD) (median onset day 24) and 79 experienced cytomegalovirus (CMV) reactivation (median onset day 35). The relative risk (RR) of developing a CMV infection for patients with acute GVHD was 2.77 times that of patients without acute GVHD (P < 0.001). CMV infection was the only independent variable significantly associated with HC in both univariate and multivariate analyses. The estimated hazard ratio (HR) of CMV infection for the development of HC was 5.57 (95% confidence interval [CI]: 2.52 to 12.33, P < 0.001). CMV infection is an independent risk factor for the development of HC after HSCT, and acute GVHD is a risk factor for CMV reactivation. Decreasing the frequency of GVHD after HSCT may result in a lower frequency of HC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Norkin M, Wingard JR (2017) Recent advances in hematopoietic stem cell transplantation. F1000Research 6:870

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lunde LE, Dasaraju S, Cao Q et al (2015) Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant 50:1432–1437. https://doi.org/10.1038/bmt.2015.162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hassan Z, Remberger M, Svenberg P et al (2007) Hemorrhagic cystitis: a retrospective single-center survey. Clin Transplant 21:659–667. https://doi.org/10.1111/j.1399-0012.2007.00705.x

    Article  PubMed  Google Scholar 

  4. Saito Y, Kumamoto T, Shiraiwa M et al (2018) Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: a single institution study. Asia Pac J Clin Oncol 14:e460–e464. https://doi.org/10.1111/ajco.13048

    Article  PubMed  Google Scholar 

  5. Droller MJ, Saral R, Santos G (1982) Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology 20:256–258. https://doi.org/10.1016/0090-4295(82)90633-1

    Article  CAS  PubMed  Google Scholar 

  6. Cesaro S, Dalianis T, Rinaldo CH et al (2018) ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother 73:12–21. https://doi.org/10.1093/jac/dkx324

    Article  CAS  PubMed  Google Scholar 

  7. Ringden O, Labopin M, Tura S et al (1996) A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Br J Haematol 93:637–645. https://doi.org/10.1046/j.1365-2141.1996.d01-1681.x

    Article  CAS  PubMed  Google Scholar 

  8. Yaghobi R, Dehghani RM, S, (2009) The role of different risk factors in clinical presentation of hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Transplant Proc 41:2900–2902. https://doi.org/10.1016/j.transproceed.2009.07.060

    Article  CAS  PubMed  Google Scholar 

  9. Tsuboi K, Kishi K, Ohmachi K et al (2003) Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 32:903–907. https://doi.org/10.1038/sj.bmt.1704240

    Article  CAS  PubMed  Google Scholar 

  10. Ost L, Lonnqvist B, Eriksson L et al (1987) Hemorrhagic cystitis – a manifestation of graft versus host disease? Bone Marrow Transplant 2:19–25

    CAS  PubMed  Google Scholar 

  11. Lee GW, Lee JH, Choi SJ, Kim S, Seol M, Kim WK, Lee JSLK (2003) Hemorrhagic cystitis following allogeneic hematopoietic cell transplantation. J Korean Med Sci 18:191–195

    Article  PubMed  PubMed Central  Google Scholar 

  12. El-Zimaity M, Saliba R, Chan K et al (2004) Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood 103:4674–4680. https://doi.org/10.1182/blood-2003-08-2815

    Article  CAS  PubMed  Google Scholar 

  13. Lu DP, Dong L, Wu T et al (2006) Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 107:3065–3073. https://doi.org/10.1182/blood-2005-05-2146

    Article  CAS  PubMed  Google Scholar 

  14. Leung AYH, Suen CKM, Lie AKW et al (2001) Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 98:1971–1978. https://doi.org/10.1182/blood.V98.6.1971

    Article  CAS  PubMed  Google Scholar 

  15. Atilla E, Atilla PA, Bozdağ SC, Demirer T (2017) A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection 45:403–411

    Article  CAS  PubMed  Google Scholar 

  16. Gaziev J, Paba P, Miano R et al (2010) Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. Biol Blood Marrow Transplant 16:662–671. https://doi.org/10.1016/j.bbmt.2009.12.009

    Article  CAS  PubMed  Google Scholar 

  17. El-Cheikh J, Devillier R, Crocchiolo R et al (2013) Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantation. Mediterr J Hematol Infect Dis 5:e2013026. https://doi.org/10.4084/MJHID.2013.026

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cantoni N, Hirsch HH, Khanna N et al (2010) Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant 16:1309–1314. https://doi.org/10.1016/j.bbmt.2010.03.020

    Article  PubMed  Google Scholar 

  19. Liu C, He M, Rooney B et al (2006) Longitudinal analysis of T-cell receptor variable β chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 12:335–345. https://doi.org/10.1016/j.bbmt.2005.09.019

    Article  PubMed  Google Scholar 

  20. Miller W, Flynn P, McCullough J et al (1986) Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 67:1162–1167. https://doi.org/10.1182/blood.v67.4.1162.bloodjournal6741162

    Article  CAS  PubMed  Google Scholar 

  21. Einsele H, Hebart H, Kauffmann-Schneider C et al (2000) Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant 25:757–763. https://doi.org/10.1038/sj.bmt.1702226

    Article  CAS  PubMed  Google Scholar 

  22. Ljungman P, Perez-Bercoff L, Jonsson J et al (2006) Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematologica 91:78–83

    PubMed  Google Scholar 

  23. Boström L, Ringdén O, Jacobsen N et al (1990) A European multicenter study of chronic graft-versus-host disease: the role of cytomegalovirus serology in recipients and donors—acute graft-versus-host disease, and splenectomy. Transplantation 49:1100–1105. https://doi.org/10.1097/00007890-199006000-00014

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Ling Zhang and Bijay Khadka contributed equally to this work.

Authors and Affiliations

  1. Department of Hematology, the Third Affiliated Hospital of Sun Yat Sen University, 600 Tianhe Avenue, Guangzhou, 510630, China

    Ling Zhang, Bijay Khadka, Jieying Wu, Yashu Feng, Bing Long, Ruozhi Xiao & Jiajun Liu

Authors
  1. Ling Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bijay Khadka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jieying Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yashu Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bing Long
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ruozhi Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jiajun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jiajun Liu.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Because of the retrospective nature, the requirement of informed patient consent was waived.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Khadka, B., Wu, J. et al. CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantation. Ann Hematol 102, 1193–1201 (2023). https://doi.org/10.1007/s00277-023-05121-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05121-9

Keywords

Search

Navigation